No Data
No Data
Nektar, Verastem Among Healthcare Additions in Russell Microcap; Assertio, Sangamo Removed
Russell 3000: Inovio, Ocugen Among Healthcare Additions; Assertio, Ginkgo Bioworks Among Deletions
Nektar Management to Present at Upcoming Investor Conferences
SAN FRANCISCO, May 30, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: Jefferies Healthcare Conference in New York City
Nektar Files to Sell 25M Shares of Common Stock for Holders
J.P. Morgan Maintains Nektar Therapeutics(NKTR.US) With Sell Rating
J.P. Morgan analyst Jessica Fye maintains $Nektar Therapeutics(NKTR.US)$ with a sell rating.According to TipRanks data, the analyst has a success rate of 49.4% and a total average return of 4.3% over
Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR) and BioNTech SE (BNTX)